Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

Altenburg AF, van de Sandt CE, Li BWS, MacLoughlin RJ, Fouchier RAM, van Amerongen G, Volz A, Hendriks RW, de Swart RL, Sutter G, Rimmelzwaan GF, de Vries RD.

Sci Rep. 2017 Aug 17;7(1):8580. doi: 10.1038/s41598-017-08719-y.

2.

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.

Link EK, Brandmüller C, Suezer Y, Ameres S, Volz A, Moosmann A, Sutter G, Lehmann MH.

Vaccine. 2017 Sep 12;35(38):5131-5139. doi: 10.1016/j.vaccine.2017.08.019. Epub 2017 Aug 14.

PMID:
28818566
3.

Sus scrofa papillomavirus 2 - genetic characterization of a novel suid papillomavirus from wild boar in Germany.

Link EK, Hoferer M, Strobel B, Rigbers K, Langenmayer MC, Sutter G, Fux R.

J Gen Virol. 2017 Aug;98(8):2113-2117. doi: 10.1099/jgv.0.000868. Epub 2017 Jul 31.

PMID:
28758619
4.

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.

Tan WG, Zubkova I, Kachko A, Wells F, Adler H, Sutter G, Major ME.

PLoS One. 2017 Jul 21;12(7):e0181578. doi: 10.1371/journal.pone.0181578. eCollection 2017.

5.

Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

Frey TR, Lehmann MH, Ryan CM, Pizzorno MC, Sutter G, Hersperger AR.

Virology. 2017 Sep;509:98-111. doi: 10.1016/j.virol.2017.06.010.

PMID:
28628829
6.

Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.

Rappuoli R, Sutter G.

Curr Opin Virol. 2017 Apr;23:vi-viii. doi: 10.1016/j.coviro.2017.06.001. No abstract available.

PMID:
28622999
7.

[Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].

Eddicks M, Szikora F, Walhöfer N, Sauter Louis C, Reese S, Banholzer E, Reiner G, Sutter G, Ritzmann M, Fux R.

Tierarztl Prax Ausg G Grosstiere Nutztiere. 2017 Apr 19;45(2):90-97. doi: 10.15653/TPG-160547. Epub 2017 Mar 22. German.

PMID:
28327779
8.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Review.

PMID:
28057259
9.

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HL, van Run PR, Fouchier RA, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.

J Virol. 2016 Oct 28;90(22):10209-10219. Print 2016 Nov 15.

10.

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes.

Lülf AT, Freudenstein A, Marr L, Sutter G, Volz A.

Virology. 2016 Dec;499:322-330. doi: 10.1016/j.virol.2016.09.006. Epub 2016 Oct 11.

PMID:
27741426
11.

Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.

Ohmer M, Weber A, Sutter G, Ehrhardt K, Zimmermann A, Häcker G.

Cell Death Dis. 2016 Aug 18;7(8):e2340. doi: 10.1038/cddis.2016.242.

12.

Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.

Excler JL, Delvecchio CJ, Wiley RE, Williams M, Yoon IK, Modjarrad K, Boujelal M, Moorthy VS, Hersi AS, Kim JH; MERS-CoV Vaccine Working Group.

Emerg Infect Dis. 2016 Aug;22(8). doi: 10.3201/eid2208.160229.

13.

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Rollier CS, Verschoor EJ, Verstrepen BE, Drexhage JA, Paranhos-Baccala G, Liljeström P, Sutter G, Arribillaga L, Lasarte JJ, Bartosch B, Cosset FL, Inchauspe G, Heeney JL.

Gene Ther. 2016 Oct;23(10):753-759. doi: 10.1038/gt.2016.55. Epub 2016 Jul 14.

PMID:
27416077
14.

Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.

Ducatez MF, Becker J, Freudenstein A, Delverdier M, Delpont M, Sutter G, Guérin JL, Volz A.

Vet Microbiol. 2016 Jun 30;189:59-67. doi: 10.1016/j.vetmic.2016.04.025. Epub 2016 Apr 26.

PMID:
27259828
15.

Low prevalence of porcine circovirus type 2 infections in farrowing sows and corresponding pre-suckling piglets in southern German pig farms.

Eddicks M, Koeppen M, Willi S, Fux R, Reese S, Sutter G, Stadler J, Ritzmann M.

Vet Microbiol. 2016 May 1;187:70-74. doi: 10.1016/j.vetmic.2016.03.010. Epub 2016 Mar 16.

PMID:
27066711
16.

CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection.

Lehmann MH, Torres-Domínguez LE, Price PJ, Brandmüller C, Kirschning CJ, Sutter G.

J Leukoc Biol. 2016 Jun;99(6):1057-64. doi: 10.1189/jlb.4MA0815-376RR. Epub 2016 Mar 18. Review.

17.

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

Volz A, Lim S, Kaserer M, Lülf A, Marr L, Jany S, Deeg CA, Pijlman GP, Koraka P, Osterhaus AD, Martina BE, Sutter G.

Vaccine. 2016 Apr 7;34(16):1915-26. doi: 10.1016/j.vaccine.2016.02.042. Epub 2016 Mar 2.

PMID:
26939903
18.

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.

Halle S, Keyser KA, Stahl FR, Busche A, Marquardt A, Zheng X, Galla M, Heissmeyer V, Heller K, Boelter J, Wagner K, Bischoff Y, Martens R, Braun A, Werth K, Uvarovskii A, Kempf H, Meyer-Hermann M, Arens R, Kremer M, Sutter G, Messerle M, Förster R.

Immunity. 2016 Feb 16;44(2):233-45. doi: 10.1016/j.immuni.2016.01.010. Epub 2016 Feb 9.

19.

Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara.

Marr L, Lülf AT, Freudenstein A, Sutter G, Volz A.

J Gen Virol. 2016 Apr;97(4):934-40. doi: 10.1099/jgv.0.000425. Epub 2016 Feb 10.

PMID:
26864442
20.

[Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].

Volz A, Fux R, Langenmayer MC, Sutter G.

Berl Munch Tierarztl Wochenschr. 2015 Nov-Dec;128(11-12):464-72. Review. German.

PMID:
26697713

Supplemental Content

Loading ...
Support Center